Bruce Trock

Bruce Trock

Johns Hopkins University

H-index: 92

North America-United States

About Bruce Trock

Bruce Trock, With an exceptional h-index of 92 and a recent h-index of 47 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of Cancer epidemiology, cancer translational research.

His recent articles reflect a diverse array of research interests and contributions to the field:

The association of subspecialty and sex with industry payments to internal medicine physicians who recently completed training

MP33-12 INDUSTRY PAYMENTS TO UROLOGISTS IN 2022: DESCRIPTIVE ANALYSIS OF THE OPEN PAYMENTS PROGRAM DATABASE

MP16-14 A PHASE II TRIAL OF INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF BCG-NAÏVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER

A Phase II Trial of Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guérin‒Naïve Nonmuscle-Invasive Urothelial Carcinoma of the Bladder

Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer

Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models

Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer

ASSOCIATION BETWEEN DIETARY NUTRIENTS AND INFLAMMATORY POTENTIAL AND BIOPSY UPGRADING IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE

Bruce Trock Information

University

Position

Professor of Urology, Johns Hopkins School of Medicine

Citations(all)

32861

Citations(since 2020)

8636

Cited By

27745

hIndex(all)

92

hIndex(since 2020)

47

i10Index(all)

272

i10Index(since 2020)

179

Email

University Profile Page

Google Scholar

Bruce Trock Skills & Research Interests

Cancer epidemiology

cancer translational research

Top articles of Bruce Trock

The association of subspecialty and sex with industry payments to internal medicine physicians who recently completed training

Journal of general internal medicine

2024/1

MP33-12 INDUSTRY PAYMENTS TO UROLOGISTS IN 2022: DESCRIPTIVE ANALYSIS OF THE OPEN PAYMENTS PROGRAM DATABASE

The Journal of Urology

2024/5

MP16-14 A PHASE II TRIAL OF INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF BCG-NAÏVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER

The Journal of Urology

2024/5

Nirmish Singla
Nirmish Singla

H-Index: 19

Bruce Trock
Bruce Trock

H-Index: 48

A Phase II Trial of Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guérin‒Naïve Nonmuscle-Invasive Urothelial Carcinoma of the Bladder

The Journal of Urology

2024/4/23

Nirmish Singla
Nirmish Singla

H-Index: 19

Bruce Trock
Bruce Trock

H-Index: 48

Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models

The Prostate

2024/4/15

Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer

European Urology Oncology

2024/4/3

ASSOCIATION BETWEEN DIETARY NUTRIENTS AND INFLAMMATORY POTENTIAL AND BIOPSY UPGRADING IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE

Urologic Oncology: Seminars and Original Investigations

2024/3/1

ERAS FOR AMBULATORY TURBT: ENHANCING BLADDER CANCER CARE (EMBRACE) RANDOMIZED CONTROLLED TRIAL

Urologic Oncology: Seminars and Original Investigations

2024/3/1

Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma

Scientific reports

2024/1/17

Likelihood of sampling prostate cancer at systematic biopsy as a function of gland volume and number of cores

Prostate Cancer and Prostatic Diseases

2024/1/6

Characterization of HOXB13 expression patterns in localized and metastatic castration‐resistant prostate cancer

The Journal of Pathology

2024/1

Risk of biochemical recurrence in patients with Grade Group 1 prostate cancer with extraprostatic extension treated with radical prostatectomy

2023/12/27

Baseline prostate health index risk category and risk category changes during active surveillance predict grade reclassification

Urologic Oncology: Seminars and Original Investigations

2023/11/1

Industry payments received by residents during training

JAMA Network Open

2023/10/2

Machine Learning for the Prediction of Adverse Pathological Outcomes in Patients Treated with Radical Prostatectomy

International journal of radiation oncology, biology, physics

2023/10/1

Predicting prostate cancer molecular subtype with deep learning on histopathologic images

Modern Pathology

2023/10/1

Development and external validation of a machine learning model for prediction of lymph node metastasis in patients with prostate cancer

European Urology Oncology

2023/10/1

MyProstateScore in men considering repeat biopsy: validation of a simple testing approach

Prostate cancer and prostatic diseases

2023/9

ERG Status at the Margin Is Associated With Biochemical Recurrence After Radical Prostatectomy With Positive Surgical Margins

Modern Pathology

2023/7/1

See List of Professors in Bruce Trock University(Johns Hopkins University)

Co-Authors

academic-engine